Alnylam Pharmaceuticals
ALNY
#629
Rank
C$54.50 B
Marketcap
C$408.22
Share price
0.67%
Change (1 day)
7.97%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company